Clinical trialsOfficial

Boston Scientific updates Vercise DBS Clinician Programmer instructions on battery recharge and longevity estimates

🇨🇦 Health Canada · Fri 13 Nov 2026

Health Canada lists a Type II recall in which Boston Scientific is correcting the instructions for use for Vercise Clinician Programmers, covering IPG recharge intervals and battery longevity estimates.

Health Canada has published a recall notice for the Clinician Programmer used with Boston Scientific's Vercise Deep Brain Stimulation (DBS) systems. The notice was posted on 13 November 2026, and the recall date is given as 4 November 2026 (identification number RA-82953).

Boston Scientific Neuromodulation Corporation is carrying out a Product Correction in the form of an update to the instructions for use (IFU). The update gives additional guidance on using the Clinician Programmer feature for the recharge interval of the implantable pulse generator (IPG) battery, and for estimating the longevity of non-rechargeable IPG batteries.

Health Canada classifies the recall as Type II and files the issue under medical devices, labelling and packaging. The notice names three models: DB-7161, DB-7164 and DB-7174. They appear under several product names, including Clinician Programmer, Vercise Clinician Programmer and Vercise DBS Clinician Programmer. Each entry is listed with more than 10 lot or serial numbers, and readers are told to contact the manufacturer for the full list.

The notice's advice is limited to contacting the manufacturer for additional information. The audience is healthcare professionals. The notice does not describe any reported injuries, device malfunctions or the number of units affected, and it does not set out any other corrective steps.

What it means for your team

  • Teams with Vercise DBS systems should check whether their Clinician Programmer models (DB-7161, DB-7164, DB-7174) are affected, and contact Boston Scientific for the full lot and serial number list.
  • The correction is a labelling change rather than a hardware change. Quality and regulatory staff should make sure the updated IFU is distributed and controlled in line with local procedures.
  • Clinical and device-support teams may want to review how recharge intervals and non-rechargeable battery longevity estimates are currently handled in the Clinician Programmer workflow, using the manufacturer's updated guidance.

Official source: Health Canada ↗

Article written by VigiEye from the official source (Health Canada). AI-assisted; check the source before acting.

More Clinical trials All →